Juan Andres Moderna, Inc. (MRNA) insider trading activity

Juan Andres is Officer of Moderna, Inc.. Currently has a direct ownership of 12,803 shares of MRNA, which is worth approximately $695,971. The most recent transaction as insider was on Apr 14, 2021, when has been sold 5,000 shares (Common Stock) at a price of $153.75 per share, resulting in proceeds of $768,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K

0% 3M change

0% 12M change

Total Value Held $695,971

Juan Andres Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 14 2021	SELL Open market or private sale	$768,750 $153.75 p/Share	5,000 Reduced 100.0%	0 Common Stock
Apr 14 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Apr 12 2021	SELL Open market or private sale	$712,300 $142.46 p/Share	5,000 Reduced 100.0%	0 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Apr 07 2021	SELL Open market or private sale	$658,150 $131.63 p/Share	5,000 Reduced 100.0%	0 Common Stock
Apr 07 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Apr 05 2021	SELL Open market or private sale	$663,150 $132.63 p/Share	5,000 Reduced 100.0%	0 Common Stock
Apr 05 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Mar 31 2021	SELL Open market or private sale	$605,500 $121.1 p/Share	5,000 Reduced 100.0%	0 Common Stock
Mar 31 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Mar 29 2021	SELL Open market or private sale	$650,250 $130.05 p/Share	5,000 Reduced 100.0%	0 Common Stock
Mar 29 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Mar 24 2021	SELL Open market or private sale	$685,350 $137.07 p/Share	5,000 Reduced 100.0%	0 Common Stock
Mar 24 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Mar 22 2021	SELL Open market or private sale	$720,950 $144.19 p/Share	5,000 Reduced 100.0%	0 Common Stock
Mar 22 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Mar 17 2021	SELL Open market or private sale	$748,900 $149.78 p/Share	5,000 Reduced 100.0%	0 Common Stock
Mar 17 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Mar 15 2021	SELL Open market or private sale	$685,000 $137.0 p/Share	5,000 Reduced 100.0%	0 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Mar 10 2021	SELL Open market or private sale	$666,200 $133.24 p/Share	5,000 Reduced 100.0%	0 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Mar 08 2021	SELL Open market or private sale	$647,050 $129.41 p/Share	5,000 Reduced 100.0%	0 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Mar 03 2021	SELL Open market or private sale	$728,000 $145.6 p/Share	5,000 Reduced 100.0%	0 Common Stock

Also insider at

AVTR

Avantor, Inc. Basic Materials

Director

EVLO

Evelo Biosciences, Inc. Healthcare

Director

Juan Andres

Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account